Navigation Links
Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors
Date:5/22/2013

NEW YORK, May 22, 2013 /PRNewswire/ -- Ohr Pharmaceutical Inc. (OTCQB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for unmet medical needs, today announced the appointment of June S. Almenoff , M.D., Ph.D., to its Board of Directors. Dr. Almenoff has extensive experience in the pharmaceutical industry, working on early and late stage drug development.

"We are delighted to have Dr. Almenoff join Ohr's Board," said Dr. Irach Taraporewala, CEO of Ohr Pharmaceutical. "She offers tremendous expertise in the areas of pharmaceutical research and development, risk management, and product licensing. We look forward to working with June as we continue to achieve significant corporate milestones including the halfway point in enrollment of the Squalamine eye drop phase II clinical trial and our proposed listing on NASDAQ, both expected by midyear."

"I am excited to be joining the board of Ohr," said Dr. June Almenoff .  "Ohr has a promising pipeline and excellent team, and I look forward to working with the Board to help drive the company toward future success." 

June S. Almenoff , M.D., Ph.D. is President and Chief Medical Officer of Furiex Pharmaceuticals, a pharmaceutical development and collaboration company (FURX: Nasdaq); she serves as the company's Principal Executive Officer and a member of the Board of Directors.  Since its inception in 2010, Furiex has completed two successful proof-of-concept programs, one of which has advanced to pivotal Phase III trials.   Prior to joining Furiex, Dr. Almenoff had over 12 years of pharmaceutical industry experience at GlaxoSmithKline. During her tenure at GSK, she was a Vice President in the Clinical Safety organization at GSK, where she chaired a Pharma-FDA working group, and she also worked in the area of scientific licens
'/>"/>

SOURCE Ohr Pharmaceutical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. China Pharmaceutical Market Guidebook Series (4) 2013 Report
2. Valeant Pharmaceuticals Announces 2013 Annual Meeting Results
3. Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors
4. Research-based Pharmaceutical Industry Launches Do You Mind? Campaign to Fight Mental and Neurological Disorders
5. Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
6. Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology
7. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm
8. Aveo Pharmaceuticals, Inc. Sued by Investor
9. Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment
10. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
11. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)...   Health 2.0 announces Bernard Tyson , ... Eric Topol , Patrick Soon-Shiong , and Samsung,s ... 8th Annual Fall Conference this coming Sept. 21-24 in ... 2.0 is set to host the very first Wearable Tech ... Consumer Tech & Wearables: Powering Healthy Lifestyles. The ...
(Date:7/28/2014)... , July 28, 2014 Pharmacyclics, Inc. (the ... will hold a conference call and audio webcast to discuss ... NASDAQ Market closes on Thursday, July 31, 2014 at 4:30 ... Date: July 31, 2014 Time: 4:30 ... (877) 303-7908 International: (678) 373-0875 A webcast replay ...
(Date:7/28/2014)... 28, 2014 STAAR Surgical Company (NASDAQ: ... of implantable lenses and delivery systems for the eye ... and conference call with investors to July 31, 2014 ... Company rescheduled the release date and conference call to ... Hideo Watanabe , President of STAAR Japan, who ...
Breaking Medicine Technology:Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 2Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 3Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014 2STAAR Surgical Moves Second Quarter Earnings Release and Conference Call One Day to July 31 2
... 2007 /PRNewswire/ --,The European Myeloma Platform (EMP) says ... plus the,steroid dexamethasone shows median survival of 35 ... two large randomized,controlled Phase III trials that enrolled ... worldwide. These updated results,were presented at the 11th ...
... ongoing phase I/II trial,of oncolytic HSV * Poster ... MARTINSRIED, Germany, June 29, 2007.--The biotech company,MediGene AG ... from the ongoing clinical trial of MediGene's cancer ... held by the European,Society for Medical Oncology. Out ...
Cached Medicine Technology:The European Myeloma Platform Reports New Survival data for,Revlimid Presented at the International Myeloma Workshop in Greece 2European Society for Medical Oncology (ESMO) Presents Data from the,Clinical Trial of MediGene's Cancer-Killing Virus in Press,Conference 2
(Date:7/29/2014)... July 29, 2014 Biocides are chemical ... control bacteria or fungi growth and to prevent degradation ... the material and its surface. It is used in ... preservation, food and beverage, paints and coatings. It is ... sanitizers, as well as in industrial applications to prevent ...
(Date:7/29/2014)... Crohn,s and Colitis Canada has invested $3.4 million ... disease and ulcerative colitis, debilitating chronic diseases that ... grants will support 9 promising research projects across ... environmental causes of the diseases, improve our understanding ... to improve patient care and quality of life. ...
(Date:7/29/2014)... materials capable of repelling bacteria have each won ... to find out why. , Their bacteria ... in hospital infections acquired through implanted medical devices ... across the globe. , Morgan Alexander, Professor of ... Paul Williams, Professor of Molecular Microbiology, in the ...
(Date:7/29/2014)... the increasing use of electronic medical records and ... for a computerized version of the preventive care ... a new study, researchers from the Indiana University ... that substantial work lies ahead to convert the ... computerized prompts for physicians, but the payoff has ...
(Date:7/29/2014)... -- The U.S. should significantly reform the federal ... to ensure that the public,s $15 billion annual ... needs, says a new report by the Institute ... through Medicare -- requires little accountability, allocates funds ... offers insufficient opportunities to train physicians in the ...
Breaking Medicine News(10 mins):Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 2Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 3Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 4Health News:Prestigious Crohn's and Colitis Canada grants fund promising Canadian research 2Health News:Bacteria resistant materials -- £2m to get the 'inside' story 2Health News:Bacteria resistant materials -- £2m to get the 'inside' story 3Health News:Study: Pediatric preventive care guidelines need retooling for computerized format 2Health News:Study: Pediatric preventive care guidelines need retooling for computerized format 3Health News:$15 billion annual public funding system for doctor training needs overhaul, says IOM 2Health News:$15 billion annual public funding system for doctor training needs overhaul, says IOM 3
... July 27 (HealthDay News) -- Intensive glucose-lowering treatment for ... of cardiovascular-related death and doctors need to be cautious ... suggests. Patients with type 2 diabetes are at ... widely used for these patients even though previous research ...
... News) -- Greater breast density is associated with an ... traits, new research says. In the study, published ... Journal of the National Cancer Institute , researchers used ... with breast cancer and a control group of 1,794 ...
... living in the United States particularly those who were ... spend for health care and are more likely to pay ... And while that disparity shrinks for naturalized Latinos ... large over time for non-citizen Latinos, the researchers found. ...
... protein that causes fireflies to glow, a Johns Hopkins team has ... the anticancer effects of the drug tamoxifen. The key is a ... breast cancer gene responds to the female hormone estrogen. In ... , the scientists show how a gene known as RET in ...
... 2011 A new study by York University researchers ... symptoms of chronic pain in women with fibromyalgia. ... effects of yoga on cortisol levels in women with ... by chronic pain and fatigue; common symptoms include muscle ...
... computed tomography (CT), researchers have identified two types of structural ... disease (COPD) that are associated with frequent exacerbations, or episodes ... the journal Radiology . COPD can damage both ... is a leading cause of death and illness worldwide. The ...
Cached Medicine News:Health News:Caution Urged in Intensive Treatment of Type 2 Diabetes 2Health News:Greater Breast Density May Raise Cancer Risk 2Health News:Big gap exists on health care spending between Latinos and whites, study finds 2Health News:Johns Hopkins researchers discover how some breast cancers alter their sensitivity to estrogen 2Health News:Yoga boosts stress-busting hormone, reduces pain: York U study 2Health News:CT shows changes in lungs associated with COPD flare-ups 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: